<DOC>
	<DOCNO>NCT01392001</DOCNO>
	<brief_summary>This observational study evaluate glucocorticoid spar effect 12 month treatment RoActemra/Actemra ( tocilizumab ) patient rheumatoid arthritis . Data collect 12 month initiation treatment RoActemra/Actemra patient treatment &gt; 5 mg prednisone equivalent least 3 month .</brief_summary>
	<brief_title>An Observational Study Glucocorticoid Use Patients With Rheumatoid Arthritis Treatment With RoActemra/Actemra ( Tocilizumab )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Patients rheumatoid arthritis rheumatologist decide introduce RoActemra Patients take 5 mg/day oral prednisone ( equivalent ) least 3 month Participation clinical trial rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>